Yudhistiara B, Weber K J, Huber P E, Ruehle A, Brons S, Haering P, Debus J, Hauswald H
Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg 69120, Germany.
National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.
Cancer Manag Res. 2019 Sep 12;11:8327-8335. doi: 10.2147/CMAR.S212310. eCollection 2019.
Considering the increasing simultaneous application of magnetic resonance imaging (MRI) for more precise photon radiotherapy, it will be likely for particle radiotherapy to adopt MRI for future image guiding. It will then be imperative to evaluate the potential biological effects of a magnetic field (MF) on particle irradiation. This study explores such effects on the highly radiosensitive TK6 lymphoblastoid human cell line.
The following three parameters were measured after irradiation with either carbon ion or proton beams using spread out Bragg peaks and applying different doses within a perpendicular 1.0 T MF: (1) cell survival fraction (14 days postirradiation), (2) treatment-specific apoptosis, which was determined through the measurement of population in the sub-G1 phase, and (3) cell cycle progression by means of flow cytometry. These were compared to the same parameters measured without an MF.
The clonogenic assay in both treatment groups showed almost identical survival curves with overlapping error bars. The calculated α values with and without an MF were 2.18 (σ=0.245) and 2.17 (σ=0.234) for carbon ions and 1.08 (σ=0.138) and 1.13 (σ=0.0679) for protons, respectively. Similarly, the treatment-specific apoptosis and cell cycle progression showed almost identical curves with overlapping error bars. A two-sample, unpooled -test analysis was implemented for comparison of all mean values and showed -values >0.05.
No statistically significant difference in biological response of the TK6 cells was observed when they were irradiated using spreadout Bragg peaks within a perpendicular 1.0 T MF as compared to those, which received the same dose without the MF. This should serve as another supporting piece of evidence toward the implementation of MRI in particle radiotherapy, though further research is necessary.
考虑到磁共振成像(MRI)越来越多地同时应用于更精确的光子放射治疗,粒子放射治疗未来采用MRI进行图像引导也将成为可能。届时,评估磁场(MF)对粒子照射的潜在生物学效应将变得至关重要。本研究探讨了磁场对高度放射敏感的TK6人淋巴母细胞系的此类效应。
在用扩展布拉格峰的碳离子或质子束照射后,在垂直的1.0 T磁场中施加不同剂量,测量以下三个参数:(1)细胞存活分数(照射后14天),(2)通过测量亚G1期细胞群体确定的治疗特异性凋亡,以及(3)通过流式细胞术检测细胞周期进程。将这些参数与在无磁场条件下测量的相同参数进行比较。
两个治疗组的克隆形成试验显示出几乎相同的存活曲线,误差条重叠。有磁场和无磁场条件下计算得到的碳离子α值分别为2.18(σ = 0.245)和2.17(σ = 0.234),质子的α值分别为1.08(σ = 0.138)和1.13(σ = 0.0679)。同样,治疗特异性凋亡和细胞周期进程显示出几乎相同的曲线,误差条重叠。对所有平均值进行比较时采用双样本、非合并t检验分析,结果显示p值>0.05。
与在无磁场条件下接受相同剂量照射的TK6细胞相比,在垂直的1.0 T磁场中使用扩展布拉格峰照射时,未观察到TK6细胞生物学反应的统计学显著差异。尽管还需要进一步研究,但这应为粒子放射治疗中实施MRI提供另一项支持证据。